James P. Flynn - 15 Dec 2022 Form 3 Insider Report for ARCA biopharma, Inc. (ORKA)

Role: Director
Signature: /s/ C. Jeffrey Dekker, Attorney-in-Fact
Issuer symbol: ORKA
Transactions as of: 15 Dec 2022
Net transactions value: $0
Form type: 3
Filing time: 19 Dec 2022, 15:17:55 UTC
Next filing: 03 Nov 2023
SEC: View on sec.gov

No securities are beneficially owned.